Article info
Basic and translational research
Extended report
An immunological biomarker to predict MTX response in early RA
- Correspondence to Professor Paul Emery, Leeds Institute of Rheumatic & Musculoskeletal Disease, NIHR Leeds Musculoskeletal Biomedical Research Unit, Chapel Allerton Hospital, Chapeltown Road, Leeds LS7 4SA, UK; p.emery{at}leeds.ac.uk
Citation
An immunological biomarker to predict MTX response in early RA
Publication history
- Received March 5, 2013
- Revised July 23, 2013
- Accepted July 24, 2013
- First published August 29, 2013.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions